GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Japan Tissue Engineering Co Ltd (TSE:7774) » Definitions » 3-Year FCF Growth Rate

Japan Tissue Engineering Co (TSE:7774) 3-Year FCF Growth Rate : 0.00% (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Japan Tissue Engineering Co 3-Year FCF Growth Rate?

Japan Tissue Engineering Co's Free Cash Flow per Share for the three months ended in Sep. 2024 was 円0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Japan Tissue Engineering Co was 29.20% per year. The lowest was -65.60% per year. And the median was 10.10% per year.


Competitive Comparison of Japan Tissue Engineering Co's 3-Year FCF Growth Rate

For the Biotechnology subindustry, Japan Tissue Engineering Co's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Japan Tissue Engineering Co's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Japan Tissue Engineering Co's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Japan Tissue Engineering Co's 3-Year FCF Growth Rate falls into.


;
;

Japan Tissue Engineering Co 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Japan Tissue Engineering Co  (TSE:7774) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Japan Tissue Engineering Co 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Japan Tissue Engineering Co's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Japan Tissue Engineering Co Business Description

Traded in Other Exchanges
N/A
Address
6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022
Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.

Japan Tissue Engineering Co Headlines

No Headlines